A phase 11 study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer Article

Industry Collaboration

cited authors

  • Rader, JS; Clarke-Pearson, D; Moore, M; Carson, L; Holloway, R; Kao, MS; Wiznitzer, I; Douglass, EC

Publication Date

  • November 1, 2003

webpage

published in

category

start page

  • 318

end page

  • 325

volume

  • 91

issue

  • 2